Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;96(35):e7508.
doi: 10.1097/MD.0000000000007508.

Laparoscopic vertical sleeve gastrectomy: A 5-year veterans affairs review

Affiliations

Laparoscopic vertical sleeve gastrectomy: A 5-year veterans affairs review

Rahman G Barry et al. Medicine (Baltimore). 2017 Sep.

Abstract

The aim of this study was to evaluate the outcomes after laparoscopic sleeve gastrectomy (SG) in a VA population.SG has recently gained popularity as a definitive bariatric surgery procedure. Data are lacking on long-term outcomes, particularly in a Veterans Affairs population.We retrospectively reviewed 223 patients who underwent SG for morbid obesity between January 2009 and June 2014. Data on length of stay, complications, interval weight loss, comorbidities, and number of therapies preoperatively and at long-term follow-up were collected.There were 164 males and 59 females who underwent SG. The mean body mass index was 45.4 kg/m. Mean excess weight loss at 1 year was 62.9%, and 47.0% at 5 years. Weight loss continued until 12 to 18 months, when there was a nadir in weight loss (P < .001). There were 4 deaths and 4 staple-line leaks, with 3 deaths related to late cardiac events. One early death occurred in a very high-risk patient. All staple-line leaks were managed nonoperatively. Of the 223 patients, 193 had hypertension, 137 diabetes, 158 hyperlipidemia, 119 obstructive sleep apnea (OSA), and 125 had gastroesophageal reflux disease. Preoperatively, patients were on a mean of 1.9 antihypertensive and 0.9 hyperlipidemic, anti-reflux and oral hypoglycemic agents. Fifty percent of patients with diabetes were on insulin and 68% with OSA used continuous positive airway pressure/bilevel positive airway pressure (CPAP/BiPAP). We found significant absolute reductions in mean antihypertensive medications (-0.8), hyperlipidemic agents (-0.4), antireflux agents (-0.4), oral hypoglycemics (-0.6), insulin use (-25%), and use of CPAP/BiPAP (-55%) (all P < .001).Laparoscopic sleeve gastrectomy is a safe and effective bariatric surgery procedure, resulting in significant early weight loss up to 18 months and long-term improvement in all major obesity-related comorbid conditions.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Body mass index and percent excess body mass index loss over time in 223 veteran patients undergoing sleeve gastrectomy. %BMIL = percent body mass index loss. Total N represents number of patients evaluated at time indicated on graph.
Figure 2
Figure 2
Total body weight and percent excess weight loss over time in 223 veteran patients undergoing sleeve gastrectomy. %EWL = percent excess weight loss. Total N represents number of patients evaluated at time indicated on graph.

Similar articles

Cited by

References

    1. WHO Media Centre: obesity and overweight. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html 2014. Accessed March, 2017.
    1. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: U.S. DHHS, Public Health Service (PHS) 1998.
    1. Allison DB, Fontaine KR, Manson JE, et al. VanItallie TB annual deaths attributable to obesity in the United States. JAMA 1999;282:1530–8. - PubMed
    1. U.S. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: Prevalence and Trends Data–Overweight and Obesity, U.S. Obesity Trends, Trends by State; Available at: https://www.cdc.gov/brfss/brfssprevalence/index.html. Accessed August, 2016.
    1. U.S. Department of Health and Human Services: The Surgeon General's call to action to prevent and decrease overweight and obesity; Office of Disease Prevention and Health Promotion; Centers for Disease Control and Prevention, National Institutes of Health. Rockville, MD; 2001.